- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05086913
Self-help Lifestyle Medicine App and Booklets for Depression
A Comparison of Self-help Lifestyle Modification Delivered by a Smartphone App and Booklets in Managing Depressive Symptoms: a Pilot Randomised Controlled Trial.
This study aims to compare self-help lifestyle medicine (LM) delivered by a smartphone app and booklets in managing depressive symptoms in a Chinese population.
This study is a randomised controlled trial. First, informed consent will be obtained from potential participants. Around 90 eligible participants will be randomly assigned to either the LM app group, the LM booklet group, and the waitlist control group, in a ratio of 1:1:1. The app group will receive an app to facilitate lifestyle modification such as video demonstrations of physical activity, diet recommendations, stress and sleep management. The booklet group will receive 8 LM booklets with identical content with the LM app. The waitlist control group will receive access to the app and booklets at the end of the study. The whole intervention lasts 8 weeks. Participants will also receive 2 messages per week from the researcher to check and prompt motivation and adherence. Participants will complete assessment before, immediately after intervention, at one month and 12-week follow up.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
As lifestyle plays an important role in the pathogenesis of depression, lifestyle medicine (LM) emerges as a new way to alleviate depressive symptoms (Sarris & O'Neil, 2016). Booklets have been shown as an inexpensive and effective delivery modality of lifestyle modification among individuals with physical conditions (Wong, Chair & Wong, 2017). Meanwhile, a recent meta-analysis supports the efficacy of mobile applications in improving depressive symptoms (Linardon, Cujipers, Carlbring, Messer & Fuller-Tyszkiewicz, 2019). Notably, the efficacy of lifestyle intervention using booklets and app have not been compared. This pilot study can inform the field about the efficacy of lifestyle intervention using two self-help delivery modalities and offer new ways to better managing depressive symptoms.
This study will be a randomised controlled trial comparing self-help LM delivered by a smartphone app and booklets in improving depression. For a pilot study, a sample size of 12 per group is recommended (Julious, 2005). Considering an estimation of 20% attrition at the three assessment time points, the final sample size is 90, with 30 participants in each group.
The LM booklet group will receive a pocket size 6-page booklet weekly that covers 8 lifestyle medicine themes including stress, relaxation, diet, exercise, sleep hygiene, worry management, mindfulness, and positive psychology. Exercises based on cognitive behavioural therapy and guidance to set and meet short term and long-term goals are featured in the booklets. The booklet series is reviewed by a panel of experts including clinical psychologists, psychiatrists, dietitians, physical trainers, and traditional Chinese Medicine practitioners. The app group will receive access to a mobile app that offers 8 modules with identical content as the wellness booklets, in addition to videos, relaxation, exercise and cooking demonstrations, daily challenges and record of goals. The waitlist control group will receive access to the app and booklets at the end of the study.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Chung Yan Chow, Undergraduate
- Telefonnummer: 39436575
- E-mail: pmhlab@cuhk.edu.hk
Studiesteder
-
-
-
Sha Tin, Hong Kong
- The Chinese University of Hong Kong
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Participants with elevated depressive symptoms as defined by PHQ-9 score 10 or above
- Hong Kong residents
- Aged 18 or above
- Able to read Chinese and type in Chinese or English
- Have an Internet-enabled mobile device (iOS or Android operating system)
Exclusion Criteria:
- Pregnancy;
- Using medication or psychotherapy for depression;
- Currently participating in other psychological intervention studies;
- Cognitive impairment;
- Having unsafe conditions and are not recommended for physical activity or a change in diet by physicians;
- Self-disclosure of any major psychiatric, medical, or neurocognitive disorders that make participation unsuitable or may interfere with the adherence of the lifestyle modification;
- Any suicidal ideation (scoring above 2 in item 9 in BDI-II) Participants with any urgent health necessity were excluded and referred.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Lifestyle medicine smartphone app
The app group will receive an app to facilitate lifestyle modification such as video demonstrations of physical activity, diet recommendations, stress and sleep management.
|
The lifestyle medicine app offers 8 modules with identical content as the wellness booklets, in addition to videos, relaxation, exercise and cooking demonstrations, daily challenges, record of goals, and ecological momentary assessments of diet, physical activity, sleep, stress and mood.
|
|
Eksperimentel: lifestyle medicine booklets
The booklet group will receive 8 lifestyle medicine and psychoeducation booklets with identical content with the lifestyle medicine app.
|
Participants will receive a pocket size 6-page booklet weekly over 8 weeks that covers 8 lifestyle medicine, mental health and CBT themes including stress, relaxation, diet, exercise, sleep hygiene, worry management, mindfulness, and positive psychology, and guides participants to set and meet short term and long-term goals.
|
|
Sham-komparator: waitlist control
The waitlist control group will receive access to the lifestyle medicine app and booklets at the end of the study.
|
The waitlist control group will receive access to the lifestyle medicine app and booklets at the end of the study.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in the Patient Health Questionnaire (PHQ-9)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-developed survey
Tidsramme: Baseline
|
A self-developed survey will collect information including demographic information (e.g., age, gender, level of education, working industry, relationship status, and location of residence), substance use, body mass index (BMI), rest-activity pattern, and social rhythms, etc.
|
Baseline
|
|
Change in the World Health Organization 5-item Well-Being Index
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
This is a 5-item measure of global subjective well-being.
The internal consistency prior to treatment was 0.86.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the Short Form (Six-Dimension) Health Survey (SF-6D)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
SF-6D is a preference-based single index measure of health.
A six-digit number represents each SF-6D health state, each digit denotes the level of one of six SF-6D dimensions: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the Perceived Stress Scale (PSS)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
The PSS measures the perceived amount of stress experienced over the past month.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the Generalized Anxiety Disorder 7-Item Scale (GAD-7)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
The GAD-7, a 7-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of anxiety over the past two weeks on a 4-point scale, "0" (not at all) to "4" (nearly every day).
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the Sheehan Disability Scale (SDS)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the Health-Promoting Lifestyle Profile (HPLP II)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
The 52-item HPLPII is composed of a total scale and six subscales to measure behaviors in the theorized dimensions of health-promoting lifestyle: spiritual growth, interpersonal relations, nutrition, physical activity, health responsibility, and stress management.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the International Physical Activities Questionnaire - Chinese version (IPAQ-C)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
Participants' sitting time, walking time and moderate and vigorous physical activity are assessed by 5 questions from the short form of the International Physical Activity Questionnaire - Chinese version.
Participants' engagement in brief strength and stamina-enhancing activity were assessed by asking the number of days they engaged in physical activity while seated and standing in the last seven days.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
|
Change in the Insomnia Severity Index (ISI)
Tidsramme: baseline, immediately post-intervention, 4-week and 12-week follow-up
|
The ISI is a 7-item scale designed to evaluate perceived insomnia severity.
Ratings on the 5-point Likert scale are obtained on the perceived severity of sleep-onset, sleep-maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeably of impairment attributed to the sleep problem, and level of distress caused by the sleep problem.
|
baseline, immediately post-intervention, 4-week and 12-week follow-up
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PSY017
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Depression
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RekrutteringAngst | Angst Depression | Depression Angstlidelse | Depression - svær depressiv lidelseNorge
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Aktiv, ikke rekrutterendeDepression Moderat | Depression Mild | Depression, teenagerForenede Stater
-
ProgenaBiomeTrukket tilbageDepression | Depression, postpartum | Depression, angst | Depression Moderat | Depression Alvorlig | Klinisk depression | Depression i remission | Depression, Endogen | Depression KroniskForenede Stater
-
Bekelu Teka WorkuJimma UniversityIkke rekrutterer endnuPrænatal depression | Mental sundhedsrelateret livskvalitet | Mødre postpartum depression | Faders postpartum depressionEtiopien
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryAktiv, ikke rekrutterendeDepression | Depression Moderat | Depression Alvorlig | Depression MildForenede Stater
-
Fondation FondaMentalGYNOVIkke rekrutterer endnuDepression | Depression hos voksne | Depression lidelseFrankrig
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RekrutteringMild depressionForenede Stater
-
Massachusetts General HospitalRekrutteringDepression | Depression - svær depressiv lidelse | Depression Kronisk | Depression hos voksne | Depressionslidelser | Depression lidelseForenede Stater
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRekrutteringDepression | Depression Moderat | Depression Alvorlig | Depression MildForenede Stater
-
University of MinnesotaAfsluttetDepression SymptomerForenede Stater
Kliniske forsøg med Lifestyle medicine smartphone app
-
Washington University School of MedicineAfsluttet
-
Environment and Health Group, Inc.Afsluttet
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Afsluttet
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Afsluttet
-
Tahel Ilan BerUkendt
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)AfsluttetForhøjet blodtryk | Nyreinsufficiens, kronisk | Mobilapplikationer | MedicinafstemningCanada
-
Alnylam PharmaceuticalsRekrutteringEn undersøgelse til evaluering af sikkerheden og tolerabiliteten af ALN-APP hos patienter med EOADTidligt opstået Alzheimers sygdomForenede Stater, Holland, Canada, Det Forenede Kongerige
-
Columbia UniversityNational Institute of Nursing Research (NINR)AfsluttetHIV/AIDSForenede Stater
-
Columbia UniversityAfsluttet
-
Alnylam PharmaceuticalsRekrutteringCerebral amyloid angiopatiSchweiz, Det Forenede Kongerige, Australien, Forenede Stater, Holland, Canada